about
Adsorption of bovine serum albumin (BSA) onto lecithin studied by attenuated total reflectance Fourier transform infrared (ATR-FTIR) spectroscopy.Sustained release veterinary parenteral products.A cyclodextrin formulation to improve use of the anesthetic tribromoethanol (Avertin(®)).Intravenous drug delivery in neonates: lessons learnt.Challenges Associated with Route of Administration in Neonatal Drug Delivery.A clinical trial of a novel emulsion for potential use as a saliva substitute in patients with radiation-induced xerostomia.The rapid detection of cefotaxime-resistant Enterobacteriaceae by HPLC.Ketamine's dose-related effects on anxiety symptoms in patients with treatment refractory anxiety disorders.Absorption and tissue tolerance of ricobendazole in the presence of hydroxypropyl-beta-cyclodextrin following subcutaneous injection in sheep.Individualised dosing of amikacin in neonates.Swelling lecithin: cholesterol implants for the controlled release of proteins.Stability of ricobendazole in aqueous solutions.Individualised dosing of amikacin in neonates: a pharmacokinetic/pharmacodynamic analysis.Simultaneous modelling of the Michaelis-Menten kinetics of paracetamol sulphation and glucuronidation.Physicochemical characterization of ricobendazole: I. Solubility, lipophilicity, and ionization characteristics.Individualising netilmicin dosing in neonates.Development and optimization of a rapid HPLC method for analysis of ricobendazole and albendazole sulfone in sheep plasma.An in vitro kinetic method for detection of precipitation of poorly soluble drugs.Investigation on Secondary Structure Perturbations of Proteins Embedded in Solid Lipid Matrices as a Novel Indicator of their Biological Activity upon In Vitro Release.Melted glyceryl palmitostearate (GPS) pellets for protein delivery.Acute low-dose ketamine produces a rapid and robust increase in plasma BDNF without altering brain BDNF concentrations.Attenuated Total Reflection Fourier Transform Infrared (ATR FT-IR) Spectroscopy as an Analytical Method to Investigate the Secondary Structure of a Model Protein Embedded in Solid Lipid Matrices.The pharmacokinetic profile of intravenous paracetamol in adult patients undergoing major abdominal surgery.Population pharmacokinetic-pharmacodynamic modelling to describe the effects of paracetamol and N-acetylcysteine on the international normalized ratio.Haematocrit influences insulin concentration measurements in dried blood spots.Evaluation of the effect of intravenous volume expanders upon the volume of distribution of gentamicin in septic neonates.Comparison of the effects of potential parenteral vehicles for poorly water soluble anticancer drugs (organic cosolvents and cyclodextrin solutions) on cultured endothelial cells (HUV-EC).Paracetamol treatment for patent ductus arteriosus: practice and attitudes in Australia and New Zealand.Investigation of an anti-activated factor X (anti-Xa) assay for the quantification of enoxaparin in human plasma.Oil-based compositions as saliva substitutes: A pilot study to investigate in-mouth retention.Lysozyme-magnesium aluminum silicate microparticles: Molecular interaction, bioactivity and release studies.Insulin resistance, glucagon-like peptide-1 and factors influencing glucose homeostasis in neonates.Service provision in the wake of a new funding model for community pharmacy.Simple measurements for prediction of drug release from polymer matrices – Solubility parameters and intrinsic viscositySafety and efficacy of maintenance ketamine treatment in patients with treatment-refractory generalised anxiety and social anxiety disordersEffect of gestational age and blood glucose on C-peptide excretion rate and clearance in neonatesIllustrative neonatal cases regarding drug delivery issuesDelayed delivery of intravenous gentamicin in neonates: impact of infusion variablesUtility of Interleukin-12 and Interleukin-10 in Comparison with Other Cytokines and Acute-Phase Reactants in the Diagnosis of Neonatal SepsisDetermination of small sample volumes in the analysis of drugs at specific sites in the oral cavity
P50
Q33269903-451955EC-94CA-47FF-A2CA-D06F98ED69D3Q35801905-266DB6F9-2B40-4721-B1A8-879F6AABC863Q37491792-E45F5890-3E45-4C09-8126-FFB8B95D5087Q38183808-99CC2074-3F1F-4B59-A763-4A86851E8E49Q38561363-E26D7A63-7DA2-4AE9-A4E7-17DC9F260F10Q38662819-AD12D621-8B01-40CE-805D-590FAD66EF47Q38766625-91A76ACF-6FCD-4347-8FEA-C74A5A75C45AQ38820487-0D8205DD-AAA5-4ECC-9549-F0C5BECC7037Q42973896-AEFD269E-6FE6-4A0C-99B2-22384EF00C24Q43298568-3F4C452C-3B14-4CF8-9FDC-98C1E1164679Q45974642-80AD7D17-D8BB-4012-9C7B-BECD7329DE6CQ46063637-50CAFEC1-F577-4EC6-AE1A-ADE7AB5CFE44Q46078844-929D50A0-CB36-49BD-B58D-AFBBDC079FF0Q46401074-6B9515BB-52D0-4E1E-B917-4012CB178208Q46406925-EAA3D231-F2DB-4EE0-A5BC-61B353B1C8AFQ46441524-360F717B-D5FB-4786-8879-D7CB366C3966Q46476207-BE8D1DAD-D357-4DDF-8A6D-CBD3F02123F8Q46731027-AB8A9608-E827-450B-BFD9-94BFF8BA016EQ47406076-FBE05E64-C360-4EF1-A641-6AA77BC2EB0CQ47641226-8265B875-17DF-404C-8EAD-89C65C50421CQ47658615-5B7C1EB1-48D0-4695-99DC-25AE01A418B5Q47664511-7571F1A6-4C58-4690-94E9-4A516F97F0F0Q48115955-AB8A6793-13A9-4C60-B330-4EDA3E4C83B1Q48191574-EA14E9D7-52A3-4A08-9CEA-EA4430FD05D0Q50278107-5CF2539D-8EDB-4432-9CA8-AD481315E4B5Q50605233-4B269A33-AF39-4313-80C8-545D21569405Q52531705-CAF6F361-46FA-4688-B166-0446A641CF9CQ52644392-783CA4F5-A561-4533-849F-F22A3AE1A748Q53162444-A6891EAC-D905-4087-A48A-6777ACF29D86Q53193490-4DC94EE0-027B-479D-8B8C-33402B0C405EQ53416971-009EB825-8917-4D6F-993A-92F9B10E27EFQ53771192-04A182D0-2978-4666-B7D4-C6ABC7CF57EDQ55012334-A9C7A4C6-6624-4364-B8C9-585EE22719C7Q59234303-4BA9A41B-4413-4FF3-8EE5-1D11667A71DBQ60683817-AD95C9E0-AF2D-4F3D-8EB6-562CB96AA5FAQ61810554-66FAE046-22D6-4C8B-A61D-13A49CF3303AQ61810567-B3663BC6-7EA5-436F-BB47-04741AD89542Q61810572-661A2880-D80F-460C-A302-05B6D1CC6A97Q61810592-31AF34D9-C098-4A8F-8C81-5C1A5ABEB58AQ72300345-8D29E743-AEC4-4105-9B0E-28461D72D4A7
P50
description
researcher
@en
name
N J Medlicott
@en
N J Medlicott
@nl
type
label
N J Medlicott
@en
N J Medlicott
@nl
prefLabel
N J Medlicott
@en
N J Medlicott
@nl
P106
P31
P496
0000-0001-9778-1947